Clinical Trials Directory

Trials / Completed

CompletedNCT05549375

Neurorehabilitation of the Hand

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
IRegained Inc. · Industry
Sex
All
Age
30 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Stroke is the number one cause of adult disability in the world. Due to the neurological damage from stroke, a vast majority of individuals suffer from hand function disability (\~70%). To improve hand function and overcome challenges from this disability, IRegained has developed the MyHandTM system, a connected mechatronic device with programmed proprietary hand function training protocols developed through deep research in neuroplasticity that provide targeted hand function therapy. When these therapeutic protocols are provided in a gamified format, it enhances the patient engagement and motivation, thereby enabling effective therapy administration with the required intensity and repetition to improve hand function. Participants who have sustained a stroke 6 months or earlier will be eligible to participate in this study, and will undergo hand function therapy for one 1-hour/session, 5 times/week, over a 3-week duration, for a total of 15 sessions. Therapy will be administered through with specific hand functions in a gamified format to enhance greater function in the hand and thereby help patients gain greater independence in performing activities of daily living. This research project will aim to understand the extent to which this approach to therapy impacts patient motivation and engagement in order to develop the most efficient and effective mode of therapy.

Conditions

Interventions

TypeNameDescription
DEVICEMyHand System Hand Rehabilitation15 1-hour patient specific sessions using the MyHand System to help improve Hand function in the affected hand of stroke survivors

Timeline

Start date
2021-08-04
Primary completion
2021-09-01
Completion
2021-09-01
First posted
2022-09-22
Last updated
2022-09-22

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05549375. Inclusion in this directory is not an endorsement.